He is a billionaire who loves a good stock, but apparently Johnson & Johnson is not among them. Berkshire Hathaway founder, Warren Buffett, decided to drop 34% of his stock in Johnson & Johnson (JNJ) during the fourth quarter of 2012, according to reports. Buffett has been selling off JNJ […]
Category: Defective Medical Devices
A patient with a metal-on-metal or any hip replacement that causes symptoms or problems requires that the individual become his/her own best advocate. First, make an appointment with an orthopedic surgeon for evaluation which includes not just a physical exam but an examination of fluid around the joint/ soft tissue […]
It is a problem usually associated with aging. A hip joint can deteriorate with additional weight, after trauma or due to disease such as arthritis. For the sufferer, the symptoms may be difficulty walking, pain, stiffness and eventually hip replacement surgery. Whether a total hip replacement (THR) or a hip […]
In one of the largest studies of its kind, researchers have determined that women have a slightly elevated chance of needing a hip revision before a man. Researchers from Kaiser Permanente looked at 35,000 hip surgeries in 46 hospitals within their healthcare system. While men had an average of 1.9 […]
It is so interesting to delve into how a corporation thinks. Not in that they think like a person – even though the U.S. Supreme Court recently gave corporations First Amendment rights – but in that they groupthink. Take the case of transvaginal mesh. A trial is underway in Superior […]
When our clients discover that their metal-on-metal (MoM) hip has failed and never went through U.S. Food and Drug Administration (FDA) approval for safety and efficacy, they ask – how did that happen? Most Americans do not understand that medical devices are largely unregulated, even for those devices that are […]
An MDL (multidistrict litigation) was established for the prosecution of individual personal injury lawsuits against Biomet in the fall of 2012. The Judicial Panel on Multidistrict Litigation (JPML) heard attorney arguments on September 20, 2012, at a hearing in New York City. The plaintiffs requested consolidation of the pending lawsuits […]
This study published in the December issue of Arthritis Care & Research is the first to look at the risk factors that could lead to a revision after a primary total hip replacement (THR). In the U.S. population, identified by Medicare claims from 29 states, patients who were younger, taller […]
January first marks a new chapter for medical device manufacturers, who will be required to pay an excise tax of 2.3 percent on total revenues. Medical devices range from small stents and CT scans to pacemakers, defibrillators, metal hips and synthetic surgical mesh. The $125-billion-a-year industry complains it will be […]
Johnson & Johnson (J&J) is fighting a patient lawsuit and seeking to have it dismissed on the grounds that the company did warn patients of the potential for metal erosion and the need for revision surgery. This California case was filed by plaintiff Loren Kransky in December 2010, just after […]
